首页> 外文期刊>Journal of immunology research. >Efficient Acquisition of Fully Human Antibody Genes against Self-Proteins by Sorting Single B Cells Stimulated with Vaccines Based on Nitrated T Helper Cell Epitopes
【24h】

Efficient Acquisition of Fully Human Antibody Genes against Self-Proteins by Sorting Single B Cells Stimulated with Vaccines Based on Nitrated T Helper Cell Epitopes

机译:通过将基于氮化的T辅助细胞表位刺激刺激的单一B细胞,在抗疫苗刺激的单一B细胞有效采集抵抗自我蛋白质的完全人抗体基因

获取原文
           

摘要

Single B cell antibody technology is a method for isolating antigen-specific B cells from human peripheral blood and obtaining antibody genes in developing antibody drugs. However, owing to immune tolerance to autoantigen, human autoantigen-specific B cells are difficult to acquire by conventional single B cell technology. In this study, we constructed a nitrated T-cell epitope named NitraTh by incorporating p-nitrophenylalanine into a universal T helper epitope. NitraTh had enhanced ability to activate CD4+ T cells and can be recognized by CD4+ T cells with different HLA class II haplotypes. This NitraTh can also break immune tolerance to autoantigens, such as human epidermal growth factor receptor 2 (HER2) and cannabinoid receptor 1, and induce strong specific IgM+ B cell responses in vitro. HER2-NitraTh vaccine can also stimulate the generation of HER2-specific IgG+ B cells in human immune system mice, which was established by cotransplanting lymphocytes and autologous dendritic cells in immunodeficient mice. We obtained 30 fully human IgG antibody genes by sorting single B cells from the human immune system mice immunized with HER2-NitraTh vaccine. The analysis of antibody genes showed that sorted B cells underwent the extensive somatic mutation of the antibody genes. We randomly selected eight genes for cloning, six of which expressed antibodies that can bind to HER2. Hence, we provided a convenient and effective method in acquiring fully human antibody genes against self-proteins, which can be used in developing therapeutic antibody drugs.
机译:单B细胞抗体技术是一种从人外周血中分离抗原特异性B细胞并在发育抗体药物中获得抗体基因的方法。然而,由于对自身抗原的免疫耐受性,常规单一B细胞技术难以获得人的自身抗原特异性B细胞。在该研究中,通过将p-硝基苯丙氨酸掺入通用T辅助表位来构建一个名为Nitrath的氮化T细胞表位。 Nitrath具有激活CD4 + T细胞的能力,可以通过具有不同HLA II类单倍型的CD4 + T细胞识别。该NITrath还可以破坏自身抗原的免疫耐受性,例如人表皮生长因子受体2(HER2)和大麻素受体1,并在体外诱导强大的特异性IgM + B细胞应答。 Her2-Nitath疫苗还可以刺激人免疫系统小鼠中的HER2特异性IgG + B细胞的产生,该小鼠由Cotoranspringing淋巴细胞和免疫缺陷小鼠中的自体树突细胞建立。通过用HER2-NITRATH疫苗免疫的人免疫系统小鼠分选单个B细胞,获得了30个全人IgG抗体基因。抗体基因的分析显示,分选B细胞经历了抗体基因的广泛体细胞突变。我们随机选择了8个基因克隆,其中六种表达可以与HER2结合的抗体。因此,我们提供了一种方便且有效的方法来获取抵抗自我蛋白质的完全人抗体基因,其可用于开发治疗性抗体药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号